Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts win NICE recommendations

Published: 16/11/2017
Pfizer's Ibrance, Novartis' Kisqali go to battle in England after discounts win NICE recommendations
Source: WWW.FIERCEPHARMA.COM

Pfizer’s Ibrance had a big head start on Novartis rival Kisqali in the U.S., but when it comes to England, new discount deals with cost-effectiveness watchdogs have the contenders on more equal footing.

Read more
Related news
Comment
Latest in blog
FACEBOOK